Interventional, Open-label, Flexible-dose, Exploratory Study of Brexpiprazole as Adjunctive Treatment of Sleep Disturbances in Patients With Major Depressive Disorder
Phase of Trial: Phase III
Latest Information Update: 16 May 2016
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Major depressive disorder; Sleep disorders
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Lundbeck A/S
- 24 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Sep 2013 New trial record
- 01 Sep 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.